Skip to main content

Table 3 Summary of CNVs detected by the Poisson-Gamma model across different laboratory strains and clinical samples

From: A Poisson hierarchical modelling approach to detecting copy number variation in sequence coverage data

  

Îł=99%

 

Îł=99.9%

Sample

Type of CNV

#Hits

#Loci

# Gene

 

#Hits

#Loci

#Gene

Largest CNV(kb)

HB3

Deletion

322

109

60

 

305

101

56

PFI1475 (2.0)

 

Amplification

246

206

119

 

60

53

46

PF11_0503 (0.6)

DD2

Deletion

279

98

58

 

265

95

55

PFL2550w (1.7)

 

Amplification

678

84

63

 

634

59

43

PFE1120w (14.8)

7G8

Deletion

243

125

83

 

205

101

61

MAL7P1.64 (1.1)

 

Amplification

343

118

106

 

215

49

37

PFL1130w (6.7)

GB4

Deletion

262

98

48

 

253

92

45

PFC0110w (2.5)

 

Amplification

108

84

79

 

47

38

36

PFL1155w (0.6)

OX005

Deletion

308

87

49

 

274

73

39

PFC0110w (2.8)

 

Amplification

1019

772

516

 

192

140

118

PFD0669c (1.0)

OX006

Deletion

170

65

35

 

167

62

33

PF07_0013 (1.3)

 

Amplification

277

226

188

 

90

70

64

MAL8P1.42 (1.1)

  1. Results refer to the number of individual hits (i.e., 100-bp windows) and loci (pooled hits where contiguous) using the credible levels Îł = 99% and 99.9% in the analysis.